Surge announces closing of a €7.5 million fundraising round to decrypt the immune system and transform precision medicine

Contributed by: Business Wire

Logo

Tags

Technology

Biotechnology

Health

Finance

Professional Services

Artificial Intelligence

Other Science

Research

Managed Care

General Health

Hospitals

Health Technology

Science

Clinical Trials

funding

More Like This

PR Newswire associated0

Cure51 raises a €15 million seed round to harness the natural power of cancer survivors and contribute to cure this life threatening disease

IMU Biosciences announces oversubscribed financing round, bringing its Series A to over $53M as it accelerates its work to decode the immune system with unprecedented resolution and scale, to transform how we understand, diagnose and treat disease

PR Newswire associated0

AZmed Secures €15 Million to Shape the Future of Medical Imaging with AI

Seroba Announces Above Target Final Close of its Fund IV at €123M ($134M)

HrFlow.ai Secures 7 Million Dollars (Pre-Series A) to Become the Global Standard for Artificial Intelligence (AI) Applied to HR Data

Semble co-founders: Mikael Landau and Christoph Lippuner

Semble Secures £30M Series C Investment Led by Revaia to Expand Europe’s Connected Healthcare Platform

NeutroFlow: Leading European Medical Consortium Awarded €2.5 Million Grant from EIC Transition Programme to Advance Predictive Biomarker Development for Immunotherapy Response

DeepCyte Raises $1.5M to Bring Single-Cell AI Toxicology to Drug Development